Authors: Dinter, H

Citation: H. Dinter, Phosphodiesterase type 4 inhibitors - Potential in the treatment of multiple sclerosis?, BIODRUGS, 13(2), 2000, pp. 87-94

Authors: Dinter, H Leuschner, A Tesch, K Dworak, D Loskiewicz, J

Citation: H. Dinter et al., Calculation of hadron yields around thick targets and doses behind concrete shielding of high-energy electron accelerators, NUCL INST A, 455(2), 2000, pp. 460-469

Authors: Dinter, H Tse, J Halks-Miller, M Asarnow, D Onuffer, J Faulds, D Mitrovic, B Kirsch, G Laurent, H Esperling, P Seidelmann, D Ottow, E Schneider, H Tuohy, VK Wachtel, H Perez, HD

Citation: H. Dinter et al., The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents, J NEUROIMM, 108(1-2), 2000, pp. 136-146

Authors: Dinter, H Leuschner, A Tesch, K Dworak, D Loskiewicz, J

Citation: H. Dinter et al., The field of scattered radiation in the tunnel of the proton storage ring HERA: measurements and calculations, NUCL INST A, 438(2-3), 1999, pp. 560-572

Authors: Pette, M Muraro, PA Pette, DF Dinter, H McFarland, HF Martin, R

Citation: M. Pette et al., Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones, J NEUROIMM, 98(2), 1999, pp. 147-156